Feasibility and willingness-to-pay for integrated community-based tuberculosis testing

被引:9
|
作者
Goswami, Neela D. [1 ]
Hecker, Emily [1 ]
Holland, David P. [1 ]
Naggie, Susanna [1 ]
Cox, Gary M. [1 ]
Mosher, Ann [1 ]
Turner, Debbie [2 ]
Torres, Yvonne [2 ]
Vickery, Carter [2 ]
Ahearn, Marshall A. [1 ]
Blain, Michela L. M. [1 ]
Rasmussen, Petra [1 ]
Stout, Jason E. [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] Wake Cty Hlth & Human Serv, Raleigh, NC 27610 USA
来源
BMC INFECTIOUS DISEASES | 2011年 / 11卷
关键词
INJECTION-DRUG USERS; HOMELESS; KNOWLEDGE; SERVICES; PROGRAM;
D O I
10.1186/1471-2334-11-305
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Community-based screening for TB, combined with HIV and syphilis testing, faces a number of barriers. One significant barrier is the value that target communities place on such screening. Methods: Integrated testing for TB, HIV, and syphilis was performed in neighborhoods identified using geographic information systems-based disease mapping. TB testing included skin testing and interferon gamma release assays. Subjects completed a survey describing disease risk factors, healthcare access, healthcare utilization, and willingness to pay for integrated testing. Results: Behavioral and social risk factors among the 113 subjects were prevalent (71% prior incarceration, 27% prior or current crack cocaine use, 35% homelessness), and only 38% had a regular healthcare provider. The initial 24 subjects reported that they would be willing to pay a median $20 (IQR: 0-100) for HIV testing and $10 (IQR: 0100) for TB testing when the question was asked in an open-ended fashion, but when the question was changed to a multiple-choice format, the next 89 subjects reported that they would pay a median $5 for testing, and 23% reported that they would either not pay anything to get tested or would need to be paid $5 to get tested for TB, HIV, or syphilis. Among persons who received tuberculin skin testing, only 14/78 (18%) participants returned to have their skin tests read. Only 14/109 (13%) persons who underwent HIV testing returned to receive their HIV results. Conclusion: The relatively high-risk persons screened in this community outreach study placed low value on testing. Reported willingness to pay for such testing, while low, likely overestimated the true willingness to pay. Successful TB, HIV, and syphilis integrated testing programs in high risk populations will likely require one-visit diagnostic testing and incentives.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Feasibility and willingness-to-pay for integrated community-based tuberculosis testing
    Neela D Goswami
    Emily Hecker
    David P Holland
    Susanna Naggie
    Gary M Cox
    Ann Mosher
    Debbie Turner
    Yvonne Torres
    Carter Vickery
    Marshall A Ahearn
    Michela LM Blain
    Petra Rasmussen
    Jason E Stout
    [J]. BMC Infectious Diseases, 11
  • [2] Willingness-to-pay for community-based insurance in Burkina Faso
    Dong, HJ
    Kouyate, B
    Cairns, J
    Mugisha, F
    Sauerborn, R
    [J]. HEALTH ECONOMICS, 2003, 12 (10) : 849 - 862
  • [3] Inequality in willingness-to-pay for community-based health insurance
    Dong, HJ
    Kouyate, B
    Cairns, J
    Sauerborn, R
    [J]. HEALTH POLICY, 2005, 72 (02) : 149 - 156
  • [4] The determinants of the willingness-to-pay for community-based prepayment scheme in rural Cameroon
    Donfouet, Hermann Pythagore Pierre
    Makaudze, Ephias
    Mahieu, Pierre-Alexandre
    Malin, Eric
    [J]. INTERNATIONAL JOURNAL OF HEALTH CARE FINANCE & ECONOMICS, 2011, 11 (03): : 209 - 220
  • [5] The determinants of the willingness-to-pay for community-based prepayment scheme in rural Cameroon
    Hermann Pythagore Pierre Donfouet
    Ephias Makaudze
    Pierre-Alexandre Mahieu
    Eric Malin
    [J]. International Journal of Health Care Finance and Economics, 2011, 11 : 209 - 220
  • [6] Gender's effect on willingness-to-pay for community-based insurance in Burkina Faso
    Dong, HJ
    Kouyate, B
    Snow, R
    Mugisha, F
    Sauerborn, R
    [J]. HEALTH POLICY, 2003, 64 (02) : 153 - 162
  • [7] Pharmacogenomics testing in a community pharmacy: patient perceptions and willingness-to-pay
    Gibson, Mara L.
    Hohmeier, Kenneth C.
    Smith, Cindy T.
    [J]. PHARMACOGENOMICS, 2017, 18 (03) : 227 - 233
  • [8] Willingness-to-Pay for Community-Based Health Insurance among Informal Workers in Urban Bangladesh
    Ahmed, Sayem
    Hoque, Mohammad Enamul
    Sarker, Abdur Razzaque
    Sultana, Marufa
    Islam, Ziaul
    Gazi, Rukhsana
    Khan, Jahangir A. M.
    [J]. PLOS ONE, 2016, 11 (02):
  • [9] FEASIBILITY OF WILLINGNESS-TO-PAY MEASUREMENT IN CHRONIC ARTHRITIS
    THOMPSON, MS
    READ, JL
    LIANG, M
    [J]. MEDICAL DECISION MAKING, 1984, 4 (02) : 195 - 215
  • [10] Public Acceptance and Willingness-to-Pay for a Future Dengue Vaccine: A Community-Based Survey in Bandung, Indonesia
    Hadisoemarto, Panji Fortuna
    Castro, Marcia C.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2013, 7 (09):